About ArtBlood
ArtBlood is a company based in Seoul (South Korea) founded in 2022.. ArtBlood has raised $4.8 million across 1 funding round from investors including Partners Investment, Korea Development Bank Europe and Korea Investment Accelerator. ArtBlood operates in a competitive market with competitors including Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.8 M (USD)
in 1 rounds
-
Latest Funding Round
$4.8 M (USD), Series A
Apr 09, 2024
-
Investors
Partners Investment
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ArtBlood
ArtBlood has successfully raised a total of $4.8M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.8 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $4.8M
-
First Round
First Round
(09 Apr 2024)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series A - ArtBlood | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ArtBlood
ArtBlood has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Partners Investment, Korea Development Bank Europe and Korea Investment Accelerator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in South Korea and the US
|
Founded Year | Domain | Location | |
|
Startup acceleration services are provided by Korea Investment Accelerator.
|
Founded Year | Domain | Location | |
|
Operates as a commercial bank providing deposits, loans, and payment services to customers.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ArtBlood
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ArtBlood
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Artblood Comparisons
Competitors of ArtBlood
ArtBlood operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a device for blood purification
|
|
| domain | founded_year | HQ Location |
Developer of the device for controlling bleeding
|
|
| domain | founded_year | HQ Location |
Medical devices for the rapid treatment of bloodstream infections and pathogen-reduction in blood banking
|
|
| domain | founded_year | HQ Location |
Innovative solutions for safer blood transfusions are developed.
|
|
| domain | founded_year | HQ Location |
Cytopheresis systems for inflammatory conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Artblood
Frequently Asked Questions about ArtBlood
When was ArtBlood founded?
ArtBlood was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Where is ArtBlood located?
ArtBlood is headquartered in Seoul, South Korea.
Is ArtBlood a funded company?
ArtBlood is a funded company, having raised a total of $4.8M across 1 funding round to date. The company's 1st funding round was a Series A of $4.8M, raised on Apr 09, 2024.
What does ArtBlood do?
ArtBlood was founded in 2022 in Seoul, South Korea, within the biotechnology sector. A cell-based extracorporeal blood production system is developed by the company to generate red blood cells. These cells serve as reagents for detecting transfusion-related antibodies and as carriers for therapeutic agents and immunostimulants in treatments. Operations focus on advancing blood-related medical technologies for clinical and diagnostic uses.
Who are the top competitors of ArtBlood?
ArtBlood's top competitors include Medcura, ExThera Medical and Lindis Blood Care.
Who are ArtBlood's investors?
ArtBlood has 5 investors. Key investors include Partners Investment, Korea Development Bank Europe, Korea Investment Accelerator, Heungkuk Securities, and One Law Partners.